Springhill Fund Asset Management (Hk) CO LTD Tarsus Pharmaceuticals, Inc. Transaction History
Springhill Fund Asset Management (Hk) CO LTD
- $20.9 Billion
- Q1 2025
A detailed history of Springhill Fund Asset Management (Hk) CO LTD transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Springhill Fund Asset Management (Hk) CO LTD holds 7,076 shares of TARS stock, worth $311,697. This represents 1.74% of its overall portfolio holdings.
Number of Shares
7,076Holding current value
$311,697% of portfolio
1.74%Shares
1 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$146 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$144 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$115 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$110 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$108 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.17B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...